Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Multimodal Treatment, Including Surgery, for Patients with Resectable M1 Lymph Node Metastases Without Organ Metastasis in Esophageal Carcinoma Showed Promising Prognosis

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kroese TE, van Laarhoven HWM, Nilsson M, et al. Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: a systematic review and meta-analysis. Eur J Cancer. 2022;166:254–69.

    Article  CAS  PubMed  Google Scholar 

  2. Zhan PL, Canavan ME, Ermer T, et al. Nonregional lymph nodes as the only metastatic site in stage IV esophageal cancer. JTO Clin Res Rep. 2022;3(12):100426.

    PubMed  PubMed Central  Google Scholar 

  3. Daiko H, Nishimura M. A pilot study of the technical and oncologic feasibility of thoracoscopic esophagectomy with extended lymph node dissection in the prone position for clinical stage I thoracic esophageal carcinoma. Surg Endosc. 2012;26(3):673–80.

    Article  PubMed  Google Scholar 

  4. Igaue S, Nozaki R, Utsunomiya D, et al. Significance of surgery for resectable M1 lymph node metastases without organ metastasis in esophageal carcinoma in the era of neoadjuvant treatment. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14562-5.

    Article  PubMed  Google Scholar 

  5. Kato K, Ito Y, Daiko H, et al. A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study. J Clin Oncol. 2022;40:238–238.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Esophageal Surgery, National Cancer Center Hospital, Tokyo, Japan

    Shota Igaue MD & Hiroyuki Daiko MD, PhD

Authors
  1. Shota Igaue MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroyuki Daiko MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroyuki Daiko MD, PhD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Igaue, S., Daiko, H. ASO Author Reflections: Multimodal Treatment, Including Surgery, for Patients with Resectable M1 Lymph Node Metastases Without Organ Metastasis in Esophageal Carcinoma Showed Promising Prognosis. Ann Surg Oncol 31, 1581–1582 (2024). https://doi.org/10.1245/s10434-023-14605-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14605-x

Search

Navigation